Atlas Trials

A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors

Clinical trial NCT05749432 · RECRUITING

Trial details

NCT number
NCT05749432
Sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2023-03-20
Primary completion
2026-01-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.